Is this you? Create Your Porfile
Avatar

Yongping Xie

Novartis

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Yongping Xie is active.

Explore More

Publication

Featured researches published by Yongping Xie.

Chemistry & Biology | 2006

A general strategy for creating inactive-conformation abl inhibitors

Barun Okram; Advait Nagle; Francisco Adrian; Christian C. Lee; Pingda Ren; Xia Wang; Taebo Sim; Yongping Xie; Xing Wang; Gang Xia; Glen Spraggon; Markus Warmuth; Yi Liu; Nathanael S. Gray

Archive | 2008

Protein kinase inhibitors and methods for using thereof

Taebo Sim; Truc Ngoc Nguyen; Baogen Wu; Yun He; Yongping Xie; Xing Wang; Guobao Zhang; Nathanael S. Gray

Journal of Medicinal Chemistry | 2010

A type-II kinase inhibitor capable of inhibiting the T315I "gatekeeper" mutant of Bcr-Abl.

Hwan Geun Choi; Pingda Ren; Francisco Adrian; Fangxian Sun; Hyun Soo Lee; Xia Wang; Qiang Ding; Guobao Zhang; Yongping Xie; Jianming Zhang; Yi Liu; Tove Tuntland; Markus Warmuth; Paul W. Manley; Jürgen Mestan; Nathanael S. Gray; Taebo Sim

Archive | 2007

COMPOSITIONS AND METHODS FOR FGF RECEPTOR KINASES INHIBITORS

Pingda Ren; Guobao Zhang; Shuli You; Taebo Sim; Nathanael S. Gray; Yongping Xie; Xing Wang; Yun He

Chemistry & Biology | 2006

A general strategy for creating

Barun Okram; Advait Nagle; Francisco Adrian; Christian C. Lee; Pingda Ren; Xingbo Wang; Taebo Sim; Yongping Xie; Gang Xia; Glen Spraggon; Markus Warmuth; Yi Liu; Nathanael S. Gray

Archive | 2007

[4,5']bipyrimidinyl-6,4'-diamine derivatives as protein kinase inhbitors

Pamela A. Albaugh; Yun He; Songchun Jiang; Pingda Ren; Xia Wang; Xing Wang; Yongping Xie

Archive | 2012

Compositions and methods for modulating lpa receptors

John Tellew; Xia Wang; Yongqin Wan; Yun Feng Xie; Shifeng Pan; Jiqing Jiang; Yongping Xie; Thomas Anthony Hunt; Lee Edwards; David Beattie; Mark Patrick Healy; Ryan West; Andrew Stuart Lister

Archive | 2007

Compounds and compositions as protein kinase inhbitors

Pingda Ren; Baogen Wu; Guobao Zhang; Yongping Xie; Barun Okram; Victor Nikulin; Xia Wang; Ha-Soon Choi

Archive | 2012

Compuestos y composiciones como inhibidores de cinasa de proteina

Shenlin Huang; Zuosheng Liu; John Tellew; Yongqin Wan; Xing Wang; Yongping Xie; Xianming Jin; Daniel Poon

Archive | 2011

N-(pyridin-2-yl)sulfonamides and compositions thereof as protein kinase inhibitors

Shifeng Pan; John Tellew; Yongqin Wan; Yongping Xie; Xing Wang; Xia Wang; Shenlin Huang; Zuosheng Liu; Qiong Zhang

Explore More

Collaboration

Dive into the Yongping Xie's collaboration.

Top Co-Authors
Avatar

Pingda Ren

Genomics Institute of the Novartis Research Foundation

View shared research outputs
Top Co-Authors
Avatar

Nathanael S. Gray

Harvard University

View shared research outputs
Top Co-Authors
Avatar

Guobao Zhang

Novartis

View shared research outputs
Top Co-Authors
Avatar

Xia Wang

Novartis

View shared research outputs
Top Co-Authors
Avatar

Xing Wang

Genomics Institute of the Novartis Research Foundation

View shared research outputs
Top Co-Authors
Avatar

Xing Wang

Genomics Institute of the Novartis Research Foundation

View shared research outputs
Top Co-Authors
Avatar

Yun He

Chongqing University

View shared research outputs
Top Co-Authors
Avatar

Taebo Sim

Korea Institute of Science and Technology

View shared research outputs
Top Co-Authors
Avatar

John Tellew

Novartis

View shared research outputs
Top Co-Authors
Avatar

Yongqin Wan

Novartis

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge